|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
[Fwd: HRT and Malignant melanoma]From: Onnig Tamizian (abf48@dial.pipex.com)Fri Mar 21 16:06:20 1997
X-Mozilla-Status: 0001 Message-ID: <33333855.30A8@dial.pipex.com> Date: Fri, 21 Mar 1997 17:39:33 -0800 From: Onnig Tamizian <abf48@dial.pipex.com> X-Mailer: Mozilla 2.02 (Win95; I; 16bit) MIME-Version: 1.0 To: ob-gyn-l Subject: HRT and Malignant melanoma Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit Dear Listmembers, I have been asked by a colleague to find out whether there is any reason to avoid HRT in a patient prevoiusly treated for malignant melanoma. In particular this refers to a 48 year old lady who had a malignant melanoma removed from her leg 16-17 years ago and required no further treatment. She had had a mole on her leg for years but noticed changes soon (months) after starting the COCP and therefore is now dubious about HRT (at present she is perimenopausal). Thanks for your help! Onnig. *********************************************************************** Dr Onnig Tamizian, Senior SHO, Queens Medical Centre, Nottingham NG7 2UH,. UK.
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Dec 2 05:19:08 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.